Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
Optimization of antiviral therapy can be crucial in the management of Ebola virus outbreaks. Here, Madelain et al. use an integrative mathematical model to correlate the dose and the time of treatment initiation with survival rate, enhanced immune response and viral clearance.
Guardado en:
Autores principales: | Vincent Madelain, Sylvain Baize, Frédéric Jacquot, Stéphanie Reynard, Alexandra Fizet, Stephane Barron, Caroline Solas, Bruno Lacarelle, Caroline Carbonnelle, France Mentré, Hervé Raoul, Xavier de Lamballerie, Jérémie Guedj |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8007c9d9b043441c879ab95a1e9f13f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Ramon Roozendaal, et al.
Publicado: (2020) -
Nonhuman primate models for SARS.
por: Bart L Haagmans, et al.
Publicado: (2006) -
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
por: Stuart D. Dowall, et al.
Publicado: (2017) -
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.
por: Joseph E Blaney, et al.
Publicado: (2013) -
Nonhuman primate models for HIV cure research.
por: Cristian Apetrei, et al.
Publicado: (2012)